Investment Rating - The report maintains a "Buy" rating for the company [4] Core Insights - The company is experiencing a steady recovery in growth momentum through channel optimization and product focus, with a 13.78% year-on-year decline in revenue for the first three quarters of 2025, totaling 3.464 billion yuan [1][4] - The third quarter revenue reached 1.092 billion yuan, showing a reduced decline of 9.95% compared to the previous quarter, indicating initial effectiveness of channel and product adjustments [1] - Key initiatives contributing to revenue improvement include the simplification of SKU and reduced promotions on low-margin products, alongside enhanced online channel operations [1] - The main brand, Winona, has shown stable performance, particularly during the Double Eleven pre-sale period, while the high-end anti-aging brand, Aikeman, has seen strong growth [1] Summary by Sections Revenue and Growth - The company achieved a total revenue of 3.464 billion yuan in the first three quarters of 2025, down 13.78% year-on-year, with a third-quarter revenue of 1.092 billion yuan, down 9.95% [1][3] - The revenue decline is narrowing, suggesting that operational adjustments are beginning to yield results [1] Profitability - The gross margin for Q3 2025 was 70.68%, a decrease of 5.67 percentage points year-on-year [2] - The net profit margin improved to 2.52%, indicating a significant enhancement in profitability compared to the same period last year [2] Future Outlook - The company is expected to continue its operational adjustments, with the performance during the Double Eleven sales event being a critical indicator of the effectiveness of its strategies [2] - The multi-brand matrix, anchored by Winona and supported by Aikeman and the newly introduced TriPollar brand, is anticipated to create a second growth curve [2] - EPS forecasts for 2025, 2026, and 2027 are projected at 1.02, 1.22, and 1.43 yuan respectively [2][3]

Core Viewpoint - The competition in the beauty and skincare sector during this year's Double Eleven shopping festival is intense, with brands aggressively promoting anti-aging claims despite regulatory risks [1][2][3]. Group 1: Marketing Strategies - Many beauty brands are using "anti-aging" and "anti-aging" as key marketing slogans to address consumer anxieties about aging [2]. - Brands like Proya and Pechoin are prominently featuring "anti-aging" in their promotional materials, with specific product claims such as "scientific anti-aging" and "visible youth in 4 weeks" [9][12]. - Despite these claims, some brands' customer service representatives have stated that their products do not have anti-aging effects, highlighting a contradiction in marketing versus product classification [10][13]. Group 2: Regulatory Compliance - The National Medical Products Administration has not recognized "anti-aging" as an approved claim under the 26 categories of cosmetic efficacy, making such claims a regulatory risk [2][15]. - Several brands have faced administrative penalties for making unapproved efficacy claims, indicating a growing concern over compliance in the industry [4][17]. - The current regulatory framework requires that any claims made must be supported by scientific evidence, which many brands fail to provide, leading to potential accusations of false advertising [15][16]. Group 3: Market Dynamics - Despite previous penalties, many brands continue to push the boundaries of regulatory compliance, suggesting that the cost of non-compliance is perceived as low compared to the potential sales benefits of appealing to consumer desires for anti-aging products [18]. - The strong consumer demand for anti-aging products drives brands to prioritize short-term profits over long-term regulatory compliance, creating a challenging environment for maintaining ethical marketing practices [18][19].

天眼查App显示，近日，南昌妤蔓化妆品有限公司成立，法定代表人为王成锋，注册资本10万人民币， 经营范围为许可项目：化妆品生产，城市配送运输服务（不含危险货物）（依法须经批准的项目，经相 关部门批准后在许可有效期内方可开展经营活动，具体经营项目和许可期限以相关部门批准文件或许可 证件为准）一般项目：进出口代理，化妆品批发，化妆品零售，技术服务、技术开发、技术咨询、技术 交流、技术转让、技术推广，化工产品销售（不含许可类化工产品），消毒剂销售（不含危险化学 品），日用百货销售，日用品销售，文具用品零售，文具用品批发，卫生用品和一次性使用医疗用品销 售，日用口罩（非医用）生产，第二类医疗器械销售，互联网销售（除销售需要许可的商品）（除依法 须经批准的项目外，凭营业执照依法自主开展经营活动）。 ...

Group 1: The North Face's New Membership Center - The North Face has opened its first membership center in the Asia-Pacific region in Shanghai, integrating retail, experience, and community functions [1] - The store features various product lines, including the Summit Series and UE City Exploration Series, and offers personalized member services such as equipment customization and cultural gift exchanges [1] - The opening event included notable guests like international climber Jimmy Chin and mountaineer Jim Morrison, emphasizing the brand's spirit of exploration [1] - The Asia-Pacific Vice President of The North Face stated that the brand aims to make physical stores a cultural hub for outdoor activities [1] - VF Corporation's Asia-Pacific President highlighted China as the group's second-largest market, with plans to enhance retail and digital capabilities [1] Group 2: La Roche-Posay's New Product Launch - La Roche-Posay launched a new supramolecular product line during the China International Import Expo, developed in collaboration with Nobel Prize-winning scientists [4] - The new products utilize unique supramolecular "B5 + Red Myrrh" ingredients for enhanced skin repair, promising a needle-free deep penetration experience [4] - Continuous use of the new supramolecular water-light lotion for four weeks is claimed to result in plump and radiant skin [4] Group 3: Balenciaga's New Fragrance Collection - Balenciaga has introduced a new fragrance collection featuring ten independent perfumes that redefine the brand's olfactory aesthetics [6][7] - The collection is centered around the concepts of "fusion and tension," merging traditional and modern perfumery techniques [6] - Each fragrance is designed to evoke specific emotional contexts, reflecting the brand's century-long heritage [6] Group 4: TOTEME's New Wide-Leg Jeans - Swedish brand TOTEME has launched new wide-leg jeans for the 2025 autumn/winter season, characterized by minimalist design and precise tailoring [10] - The jeans feature a high-waisted design and floor-length proportions, enhancing body lines while maintaining a relaxed silhouette [10] - Available in three colors: cold blue, washed black, and deep blue, the jeans are suggested to be worn in a larger size for a casual fit [10] Group 5: ZARA's SRPLS Collection - ZARA has released the SRPLS 2025 autumn/winter collection, inspired by "uniform" aesthetics to balance functionality and style [13] - The collection emphasizes practical design with precise cuts and comfortable fabrics, creating a "fashion toolbox" for seasonal wear [13] - Women's wear features workwear and trench coat silhouettes, while men's wear draws inspiration from 1950s Ivy League styles [13] Group 6: GANNI's Collaboration with Disney - Danish fashion brand GANNI has partnered with Disney to launch a new capsule collection inspired by the classic character Daisy Duck [17] - The collection reinterprets GANNI's signature elements with playful prints and accessories, showcasing a unique and vibrant style [17]

Core Viewpoint - Shiseido has significantly lowered its earnings forecast, expecting a consolidated net loss of 52 billion yen for the fiscal year 2025, primarily due to asset impairment losses from underperforming acquired American brands [2][4]. Financial Performance - For the fiscal year 2025, Shiseido anticipates a consolidated net loss of 52 billion yen, a substantial downgrade from a previous forecast of a profit of 6 billion yen, marking the largest loss in the company's history [2]. - Revenue for the fiscal year 2025 is projected to decrease by 3% year-on-year to 965 billion yen, falling short of the earlier estimate of 995 billion yen [4]. - For the first nine months of fiscal year 2025, the company reported a loss of 43.9 billion yen, compared to a profit of 75.4 million yen in the same period last year [4]. Asset Impairment Issues - The primary reason for the asset impairment in the U.S. business is the underperformance of the skincare brand "Drunk Elephant," acquired in 2019 for approximately 90 billion yen [6]. - Shiseido has faced asset impairment issues from previous acquisitions, including Bare Escentuals and Laura Mercier, leading to significant losses in past fiscal years [6][7]. Strategic Changes - Shiseido plans to implement layoffs and close its research facility in Singapore as part of its restructuring efforts, aiming for a total of over 70 billion yen in core operating profit by fiscal year 2026 [8]. - The new mid-term management plan for fiscal year 2030 emphasizes a shift in brand management strategy, with a focus on centralized decision-making from Japan's headquarters and a unified global brand strategy [8]. Market Challenges - The company faces increasing criticism for optimistic earnings forecasts and governance issues, with its stock price significantly declining from a peak of 9,250 yen in 2018 to around 2,000 yen recently [9]. - The competitive landscape in the premium cosmetics market is intensifying, raising questions about Shiseido's ability to effectively implement its brand rebuilding and market expansion strategies [9].

天眼查App显示，近日，厦门爱泓泥润化妆品有限公司成立，法定代表人为林爱梅，注册资本100万人 民币，经营范围为一般项目：化妆品零售；互联网销售（除销售需要许可的商品）；卫生用品和一次性 使用医疗用品销售；个人卫生用品销售；日用杂品销售；服装辅料销售；日用品销售；针纺织品销售； 日用百货销售；厨具卫具及日用杂品零售；信息咨询服务（不含许可类信息咨询服务）；信息技术咨询 服务；针纺织品及原料销售；纸制品销售；化妆品批发；日用化学产品销售。（除依法须经批准的项目 外，凭营业执照依法自主开展经营活动）。 ...

Core Viewpoint - Jingtai Holdings (02228) has successfully developed and validated two innovative topical active ingredients for hair loss prevention and growth, leveraging its industry-leading AI molecular discovery platform, marking its entry into the consumer health sector [1] Group 1: Product Development - The two active ingredients developed are small molecule Remeanagen (XTP-118) and peptide AquaKine (XTP-016), both of which have successfully passed the INCI registration in the United States [1] - The combined formulation product Groland has also received FDA registration, indicating regulatory approval for market entry [1] Group 2: Strategic Partnerships - Jingtai's wholly-owned subsidiary Ailux has entered into a multi-target strategic cooperation and platform licensing agreement with Eli Lilly, with a total agreement value of up to $345 million, including several million dollars in upfront payments and milestone payments [1] - This partnership aims to accelerate the discovery and development of bispecific antibodies across multiple therapeutic areas, utilizing Ailux's proprietary platform and AI antibody research capabilities [1] - This collaboration follows a previous $250 million agreement between Jingtai Technology and Eli Lilly for AI small molecule drug development [1]

Core Insights - KOSÉ Corporation reported a slight increase in overall sales amid ongoing adjustments in the global beauty market, but is facing profit challenges and is exploring new growth paths through structural adjustments [1][20]. Financial Performance - For the first three quarters, KOSÉ's sales reached 240.5 billion yen (approximately 11.1 billion RMB), a year-on-year increase of 0.7% (1.3% excluding currency effects) [1][2]. - Operating profit decreased by 27.8% to 13.5 billion yen (approximately 623 million RMB), primarily due to increased sales management expenses [1][2]. - The net profit attributable to shareholders was 9.3 billion yen (approximately 426 million RMB), showing a slight decline of 0.3% [2]. Segment Performance - The cosmetics division reported sales of 189.9 billion yen (approximately 8.77 billion RMB), a year-on-year increase of 1.3%, but operating profit fell by 24.6% to 11.6 billion yen (approximately 536 million RMB) [3][4]. - The beauty division's sales were 48.3 billion yen (approximately 2.23 billion RMB), down 2.1%, with operating profit declining by 22.7% to 5.2 billion yen (approximately 240 million RMB) [3][4]. - The other segment saw the highest growth, with sales of 2.1 billion yen (approximately 97 million RMB), an increase of 18.6%, and operating profit of 1.1 billion yen (approximately 51 million RMB), up 17.9% [3][4]. Brand Performance - The DECORTÉ brand showed signs of recovery after two years of decline, with sales increasing by 1.2% to 50.9 billion yen (approximately 2.35 billion RMB) [6][8]. - Tarte's sales slightly increased by 0.96% to 52.4 billion yen (approximately 2.42 billion RMB), surpassing DECORTÉ [5]. - ALBION's net sales reached 44.9 billion yen (approximately 2.07 billion RMB), achieving a growth of 2.75% [5]. Regional Performance - The Japanese market saw a significant increase in net sales by 15% to 157 billion yen (approximately 7.25 billion RMB) [11]. - The North American market reported a 3% increase in net sales to 53.5 billion yen (approximately 2.47 billion RMB) [9]. - The Asian market (excluding Japan) was the only region to experience a decline, with net sales down 1% to 29.8 billion yen (approximately 1.38 billion RMB) [13][17]. Strategic Adjustments - KOSÉ is undergoing internal structural reforms, including changes in organization and personnel, to address challenges and enhance brand synergy [22][24]. - The company has acquired a 10% stake in foxtale Consumer Pvt. Ltd. to strengthen its presence in the Indian market [22]. - KOSÉ plans to implement cost-effective promotional activities and focus on key brands to drive growth in the Chinese market [20][22].

Core Viewpoint - The consumer sector is showing signs of recovery, driven by favorable policies, rising CPI, and the imminent closure of Hainan Free Trade Port, leading to increased investment enthusiasm in the sector [2][4]. Group 1: Consumer Sector Analysis - The consumer sector is believed to be at the bottom, with fundamentals gradually improving, as indicated by the third-quarter reports [4]. - The "14th Five-Year Plan" emphasizes the importance of consumption, suggesting a positive outlook for the sector [4]. - Key investment opportunities include the restaurant chain sector, which is nearing the end of price wars, and companies like Anjiexin Foods and Lihai Foods are seeing improved net profit margins [4]. Group 2: Duty-Free Industry Insights - Hainan's duty-free sales data shows a significant recovery in Q3 2025, with a notable increase in average transaction value, and a stable outlook for Q4 [5]. - Continuous policy support, including a clear timeline for the island's closure and an expanded range of duty-free products, is expected to enhance the operational conditions for companies like China Duty Free Group and Hainan Development [5]. Group 3: Structural Upgrades in Consumption - The toy industry is evolving with IP incubation and category innovation, favoring leading companies with strong design and supply chain capabilities [6]. - The beauty industry is integrating medical, beauty, and health services, which is expected to enhance customer spending and repeat purchases [6]. - The consumer industry is transitioning from "functional supply" to "scenario value supply," indicating a structural upgrade in brand consumer goods [6]. Group 4: New Consumption Trends - Four new consumption themes are emerging: 1. Brand globalization 2.0, focusing on pricing power and emerging markets [7]. 2. Emotional value sectors like trendy toys and pet products are expected to benefit from rising GDP per capita [7]. 3. AI-driven consumption in service sectors is showing potential for profitability [7]. 4. Channel transformation emphasizing user experience and operational efficiency, particularly in instant retail and cost-effective dining [7]. Group 5: High-Growth Opportunities in Emotional Consumption - The gold and jewelry sector is undergoing significant changes, with rising gold prices and a shift towards emotional consumption, suggesting opportunities in high-end and trendy gold segments [8]. - Retail e-commerce is focusing on offline retail transformation and AI-enabled cross-border e-commerce leaders [8]. - The cosmetics sector is seeing growth in domestic brands that meet emotional value and safety ingredient innovation [8]. - The medical beauty sector remains resilient, with opportunities in differentiated products and mergers in downstream medical beauty institutions [8].

| 指数 | 收盘 | | 涨跌（％） | | | --- | --- | --- | --- | --- | | 名称 | （点） | 1 日 | 5 日 | 1 月 | | 上证指数 | 4019 | 0.53 | 3.12 | 1.06 | | 深证综指 | 2529 | 0.4 | 0.95 | 0.35 | | 风格指数 (％) | 昨日 | 近 1 个月 | 近 6 个月 | | --- | --- | --- | --- | | 大盘指数 | 0.24 | 1.7 | 22.02 | | 中盘指数 | 0.39 | -0.76 | 30.29 | | 小盘指数 | 0.32 | 0.57 | 25.36 | | 涨幅居前 行业(％) | 昨日 | 近 1 个月 | 近 6 个月 | | 跌幅居前 行业(％) | 昨日 | 近 1 个月 | 近 6 个月 | 今日重点推荐 2025 年 11 月 11 日 ◼ 白酒行业点评：黎明前夕，曙光将至 ——白酒进入底部战 略性布局期 ◼ 战略性看多白酒。复盘 2012-2015 板块表现，股价拐点领先基本面拐点出 现，我们判断基本面拐点 26Q3 出现。展 ...